Back
SPDR S&P Global Infrastructure ETF Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Sell
46
GII
SPDR S&P Global Infrastructure ETF
Last Price:
$70.22
Seasonality Move:
-1.31%
Sell
47
RNA
Avidity Biosciences, Inc.
Last Price:
$72.16
Seasonality Move:
17.26%
Sell
46
SPDR S&P Global Infrastructure ETF (GII)
is a Sell
Is SPDR S&P Global Infrastructure ETF a Buy, Sell or Hold?
-
The current SPDR S&P Global Infrastructure ETF [GII] share price is $70.27. The Score for GII is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
GII is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Avidity Biosciences, Inc. (RNA)
is a Sell
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $72.13. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GII Stock Price Chart
What is SPDR S&P Global Infrastructure ETF's stock price today?
-
The SPDR S&P Global Infrastructure ETF share price today is $70.27The current trend is relatively stagnant and GII is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $72.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
GII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 50.13 | Buy |
| Chaikin Money Flow: | 16390 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.74 - 71.1) | Sell |
| Bollinger Bands (100): | (68.84 - 70.6) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 19.7 | Buy |
| Relative Strength Index (14 RSI): | 72.86 | Buy |
| Chaikin Money Flow: | 196399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.2 - 72.08) | Buy |
| Bollinger Bands (100): | (44.1 - 69.34) | Buy |
GII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 70.52 | Sell |
| 50-day SMA: | 70.34 | Sell |
| 200-day SMA: | 67.23 | Buy |
| 8-day EMA: | 70.03 | Buy |
| 20-day EMA: | 70.23 | Buy |
| 50-day EMA: | 69.1 | Buy |
| 200-day EMA: | 45.15 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.12 | Buy |
| 20-day SMA: | 71.78 | Buy |
| 50-day SMA: | 67.88 | Buy |
| 200-day SMA: | 43.82 | Buy |
| 8-day EMA: | 59.73 | Buy |
| 20-day EMA: | 36.34 | Buy |
| 50-day EMA: | 17.62 | Buy |
| 200-day EMA: | 4.88 | Buy |
SPDR S&P Global Infrastructure ETF Earnings Growth & GII Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
SPDR S&P Global Infrastructure ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||